Standard Biotools (LAB) Tax Provisions (2010 - 2026)

Standard Biotools (LAB) has reported Tax Provisions for 17 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions rose 116.42% year-over-year to $100000.0 in Q2 2026; TTM through Jun 2026 was -$37.0 million, a 86.18% decrease from a year earlier, with the FY2025 full-year figure at -$37.9 million, down 99.53% from the prior year.
• Tax Provisions was $100000.0 for Q2 2026 at Standard Biotools, up from $11000.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $301000.0 in Q2 2023 and troughed at -$35.9 million in Q4 2025.
• A 5-year average of -$4.2 million and a median of -$54000.0 in 2025 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 150.0% in 2023, down 23238.57% in 2023.
• Over 5 years, Tax Provisions stood at $70000.0 in 2022, then slumped by 23238.57% to -$16.2 million in 2023, then slipped by 19.05% to -$19.3 million in 2024, then tumbled by 86.34% to -$35.9 million in 2025, then soared by 100.28% to $100000.0 in 2026.
• The last three Tax Provisions figures came in at $100000.0 (Q2 2026), $11000.0 (Q1 2026), and -$35.9 million (Q4 2025), per Business Quant data.